KWS BioTest is a cutting edge preclinical CRO which works closely with clients to develop lead compounds as novel treatments for human disease.
Our staff are specialists in the fields of infection, inflammation, immunology and pain, and can therefore help you with model selection, study design and data interpretation in order to maximise value to your programmes.
We routinely undertake bespoke assay development in order to better support customer projects.
KWS BioTest offers fully integrated support across the full breadth of drug discovery services, employing a wide range of in vitro and in vivo models in order to support target validation, hit-to-lead and lead optimisation programmes in infection, autoimmunity, inflammation, allergy and pain;
The ideal partner for research.
In addition to offering a wide range of validated in vitro screening assays, cell biology capabilities and in vivo models, KWS BioTest routinely works with clients to develop new assay systems to meet the individual needs of their programmes.
We understand that the ideal model to test your target or PD marker is not always available. Our highly trained business development and scientific staff are able to provide literature review of potential models and work with customers to define an effective program of work aimed at developing assays and validating them to support drug discovery.
KWS BioTest is an established preclinical contract research organisation that brings together internationally renowned scientific expertise in a commercially managed environment... Read More